Science Market Update

UCLA Researchers I.D. Tumor-Fueling Mechanism

Posted by Robert Larkin on Tue, Aug 04, 2015

Like any living organism, cancer cells rely on fuel in order to survive and grow. Unfortunately for many, the growth of cancer cells is extremely deleterious to human health. That is why a major facet of cancer research currently involves locating and preventing the mechanism for fueling cancer cells.

Read More

Tags: CA, University of California Los Angeles, cancer research, California, Los Angeles, Cancer Treatment, 2015, LAVS, UCLA, Research Funding, Life Science, Biotechnology Vendor Showcase, Southwest Region, Prostate cancer

WSU Researcher Receives $2M for Prostate Cancer Trials

Posted by Robert Larkin on Fri, May 29, 2015

Prostate cancer is the most common cancer among American men, with about 200,000 men diagnosed yearly and an approximately 10% death rate, according to the Centers for Disease Control and Prevention (CDC). Furthermore, prostate cancer is one of the leading causes of cancer death among men of all races and Hispanic origin populations.

Read More

Tags: Bioresearch, WSU Pullman, Washington University, WA, cancer research, Washington State University, 2015, BioResearch Product Faire Event, Research Funding, Pullman, Prostate cancer

UCLA Studies Radiation's Prevalence in Prostate Cancer Treatments

Posted by Robert Larkin on Tue, Mar 10, 2015

While not necessarily always the best course of treatment, the majority of men with prostate cancer will go with radiation treatment when confronted with options for treating the potentially deadly disease. Unlike other options, including surgery and chemotherapy, radiation treatment is a relatively “outpatient” procedure - with no anesthetic needed, targeted effectiveness, and relatively few short term side effects.

Read More

Tags: CA, University of California Los Angeles, cancer research, California, LA, 2015, LAVS, UCLA, Biotechnology Vendor Showcase Event, Prostate cancer

Georgetown Bioresearchers Make Strides to Treat Prostate Cancer

Posted by Laura Braden on Mon, Feb 16, 2015

Through testing mice that have an abnormality in certain common chromosomes that are found in prostate cancer, researches from the Georgetown Lombardi Comprehensive Cancer Center were able to prevent tumors from growing and spreading with the help of the drug YK-4-279(Photo of lab mouse by Rama, courtesy of Wikimedia Commons). 

Read More

Tags: Washington DC, Northeast, 2015, Geotwn, BioResearch Product Faire Event, Georgetown University Medical Center, YK-4-279, Prostate cancer

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!